Managing Comorbid Attention Deficit Hyperactivity Disorder (ADHD) in Adults With Substance Use Disorder (SUD): What the Addiction Specialist Needs to Know

被引:1
|
作者
Johnson, Joe [1 ]
Morris, Sarah [2 ]
George, Sanju [3 ]
机构
[1] Hollins Pk Hosp, North West Boroughs Partnership NHS Fdn Trust, North West Lead UKAAN UK Adult ADHD Network, NW Boroughs Adult ADHD Serv, Liverpool, Merseyside, England
[2] Hollins Pk Hosp, North West Boroughs Healthcare NHS Fdn Trust, Liverpool, Merseyside, England
[3] Rajagiri Coll Social Sci Autonomous, Rajagiri Sch Behav Sci & Res, Kochi 683104, Kerala, India
来源
ADDICTIVE DISORDERS & THEIR TREATMENT | 2021年 / 20卷 / 03期
关键词
attention deficit hyperactivity disorder; substance use disorder; comorbidity; management; DEFICIT/HYPERACTIVITY DISORDER; ALCOHOL; MANAGEMENT; SYMPTOMS;
D O I
10.1097/ADT.0000000000000237
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD) often co-exist and the link between the 2 is bidirectional, with higher rates of ADHD symptoms found in the SUD population and higher rates of SUD found among the ADHD population. Some possible mechanisms which could explain the increased risk of developing a SUD in those who have ADHD include self-medication, both ADHD and SUD arising from dysregulation of 1 or more of the dopaminergic circuits, genetic factors as well exposure to parental SUD. Given the complex relationship between ADHD and SUD, those working in SUD services should be vigilant to ADHD as a possible comorbid diagnosis and refer to a specialist ADHD service for further assessment where appropriate. On the basis of a detailed clinical assessment, it has to be decided whether SUD or ADHD should be the priority for treatment or if they both ought to be; in either case, ADHD and SUD treatment services must work collaboratively. The recommended first line pharmacological treatment option for adolescents and adults with ADHD is a stimulant medication, with nonstimulants being reserved as a second or third line option. In the brief review paper, the authors further discuss the various medications for treatment of ADHD, the benefits and risks of treating ADHD in those with SUD, discuss the role of specialist ADHD treatment services, and illustrate these with the help of 2 anonymized case vignettes.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 50 条
  • [41] Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults
    Boomsma, Dorret I.
    Saviouk, Viatcheslav
    Hottenga, Jouke-Jan
    Distel, Marijn A.
    de Moor, Marleen H. M.
    Vink, Jacqueline M.
    Geels, Lot M.
    van Beek, Jenny H. D. A.
    Bartels, Meike
    de Geus, Eco J. C.
    Willemsen, Gonneke
    PLOS ONE, 2010, 5 (05):
  • [42] Comorbid Attention-Deficit/Hyperactivity Disorder and Mood Disorder in a South African Sample of Substance Use Disorder Patients
    Truter, Ilse
    Regnart, Judith
    Meyer, Anneke
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [43] Survey of attention deficit hyperactivity disorder in adults
    Hausotter, W.
    NERVENARZT, 2012, 83 (05): : 618 - +
  • [44] Prevalence of Attention Deficit Hyperactivity Disorder in adults individuals with addiction disorders
    Auriemma, Francesco
    Direnzo, Giovanni Francesco Maria
    Pero, Dina
    Boccassi, Luca
    Carbone, Vincenzo
    Cefalo, Giuseppe
    Cervelli, Claudia
    Colurcio, Barbara
    Costrini, Paola
    Cortese, Elena
    Davide, Chiara
    Forino, Giorgia Maria
    Garofano, Rossella
    Maione, Florinda
    Marguccio, Elvio
    Navarra, Antimo
    Nunzi, Marco
    Pirrotta, Federica
    Pizzirusso, Anna
    Scarpino, Valentina
    Tulino, Maria Sofia
    Leonardi, Claudio
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2023, 25 (06) : 7 - 15
  • [45] A study and comparison of the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among patients with substance use disorder and normal people
    Farhoodi, Farzad
    Rostami, Reza
    Abdolmanafi, Atefe
    Amiri, Mohsen
    WCPCG 2010, 2010, 5 : 892 - 895
  • [46] Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder
    Vilar-Ribo, Laura
    Sanchez-Mora, Cristina
    Rovira, Paula
    Richarte, Vanesa
    Corrales, Montserrat
    Fadeuilhe, Christian
    Arribas, Lorena
    Casas, Miquel
    Ramos-Quiroga, Josep Antoni
    Ribases, Marta
    Soler Artigas, Maria
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2021, 186 (03) : 140 - 150
  • [47] Need for Care and Life Satisfaction in Adult Substance Use Disorder Patients With and Without Attention Deficit Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
    Kronenberg, Linda M.
    Goossens, Peter J. J.
    van Etten, Derk M.
    van Achterberg, Theo
    van den Brink, Wim
    PERSPECTIVES IN PSYCHIATRIC CARE, 2015, 51 (01) : 4 - 15
  • [48] Parenting in adults with attention-deficit/hyperactivity disorder (ADHD)
    Johnston, Charlotte
    Mash, Eric J.
    Miller, Natalie
    Ninowski, Jerilyn E.
    CLINICAL PSYCHOLOGY REVIEW, 2012, 32 (04) : 215 - 228
  • [49] Diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults
    Stieglitz, Rolf-Dieter
    Roesler, Michael
    ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2006, 54 (02): : 87 - 98
  • [50] Personality profiles in adults with attention deficit hyperactivity disorder (ADHD)
    Perroud, Nader
    Hasler, Roland
    Golay, Nicolas
    Zimmermann, Julien
    Prada, Paco
    Nicastro, Rosetta
    Aubry, Jean-Michel
    Ardu, Stefano
    Herrmann, Francois R.
    Giannakopoulos, Panteleimon
    Baud, Patrick
    BMC PSYCHIATRY, 2016, 16